NVDA Stock Vs. ADI: The Battle For The Next Rally — Neutral

ADI   Forbes — January 30, 2026

Analog Devices increased by 16% over the last month. You might feel inspired to purchase more stock, or perhaps you are considering reducing your holdings.

image for news NVDA Stock Vs. ADI: The Battle For The Next Rally

AMD Stock's Real Rank Among Semi Giants — Positive

AMD   Forbes — January 30, 2026

As of January 29, 2026, Advanced Micro Devices (AMD) stock has outperformed most of its peers over the last year. Nevertheless, how does it really stack up against competitors that are rapidly growing in the flourishing AI and data-center market?

image for news AMD Stock's Real Rank Among Semi Giants

Robert Half International Q4 Earnings & Revenues Beat Estimates — Positive

RHI   Zacks Investment Research — January 30, 2026

RHI tops Q4 earnings and revenue estimates despite year-over-year declines, as Talent Solutions weakens while Protiviti shows relative resilience.

image for news Robert Half International Q4 Earnings & Revenues Beat Estimates

3 Top Copper Stocks to Watch as Copper Prices Skyrocket: BHP, FCX, SCCO — Positive

BHP  FCX  SCCO   24/7 Wall Street — January 30, 2026

Major copper producers rallied Thursday as the red metal extended its fourth-quarter run, driven by supply disruptions in South America, China's infrastructure stimulus, and accelerating demand from electric vehicle and renewable energy sectors.

image for news 3 Top Copper Stocks to Watch as Copper Prices Skyrocket: BHP, FCX, SCCO

Diageo tipped for upside if it leans further into the mainstream — Positive

DEO   Proactive Investors — January 30, 2026

Diageo PLC (LSE:DGE) could revive performance if it leans harder into mainstream spirits and steps back from premiumisation, that's according to analysts at RBC, who have repeated an 'Outperform' rating and £20.00 price target. RBC said the most plausible route to recovery is a bigger push into mainstream price points and a less passive stance on category growth.

image for news Diageo tipped for upside if it leans further into the mainstream

Protalix wins EU panel backing for expanded dosing of Fabry disease drug — Positive

PLX   Proactive Investors — January 30, 2026

Protalix Biotherapeutics Inc (NYSE-A:PLX, FRA:PBDA) said on Friday that the European Medicines Agency's human medicines committee has issued a positive opinion recommending approval of an expanded dosing regimen for Elfabrio, its treatment for Fabry disease, in adult patients. The Committee for Medicinal Products for Human Use (CHMP) recommended approval of a 2 mg/kg every-four-weeks dosing schedule for Elfabrio in adult Fabry patients who are stable on enzyme replacement therapy, following a re-examination of the application.

image for news Protalix wins EU panel backing for expanded dosing of Fabry disease drug

Chevron delivers mixed earnings for fourth quarter — Neutral

CVX   Proactive Investors — January 30, 2026

Chevron Corporation (NYSE:CVX, XETRA:CHV) posted mixed earnings for the fourth quarter, with profit above Wall Street estimates but revenue falling short. Adjusted earnings for the period were $3 billion, or $1.52 per share, exceeding analyst expectations of roughly $1.45 per share.

image for news Chevron delivers mixed earnings for fourth quarter

Beyond analysts' top-and-bottom-line estimates for Boston Scientific (BSX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2025.

image for news Boston Scientific (BSX) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Ares Capital (ARCC) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates — Positive

ARCC   Zacks Investment Research — January 30, 2026

Besides Wall Street's top-and-bottom-line estimates for Ares Capital (ARCC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.

image for news Ares Capital (ARCC) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates

Unveiling Lilly (LLY) Q4 Outlook: Wall Street Estimates for Key Metrics — Neutral

LLY   Zacks Investment Research — January 30, 2026

Get a deeper insight into the potential performance of Lilly (LLY) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

image for news Unveiling Lilly (LLY) Q4 Outlook: Wall Street Estimates for Key Metrics

Unveiling MPLX LP (MPLX) Q4 Outlook: Wall Street Estimates for Key Metrics — Positive

MPLX   Zacks Investment Research — January 30, 2026

Beyond analysts' top-and-bottom-line estimates for MPLX LP (MPLX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2025.

image for news Unveiling MPLX LP (MPLX) Q4 Outlook: Wall Street Estimates for Key Metrics

Stay Ahead of the Game With AbbVie (ABBV) Q4 Earnings: Wall Street's Insights on Key Metrics — Neutral

ABBV   Zacks Investment Research — January 30, 2026

Get a deeper insight into the potential performance of AbbVie (ABBV) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

image for news Stay Ahead of the Game With AbbVie (ABBV) Q4 Earnings: Wall Street's Insights on Key Metrics

Insights Into Yum (YUM) Q4: Wall Street Projections for Key Metrics — Neutral

YUM   Zacks Investment Research — January 30, 2026

Evaluate the expected performance of Yum (YUM) for the quarter ended December 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

image for news Insights Into Yum (YUM) Q4: Wall Street Projections for Key Metrics

Countdown to Uber (UBER) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS — Neutral

UBER   Zacks Investment Research — January 30, 2026

Get a deeper insight into the potential performance of Uber (UBER) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

image for news Countdown to Uber (UBER) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS

Curious about CME (CME) Q4 Performance? Explore Wall Street Estimates for Key Metrics — Neutral

CME   Zacks Investment Research — January 30, 2026

Evaluate the expected performance of CME (CME) for the quarter ended December 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

image for news Curious about CME (CME) Q4 Performance? Explore Wall Street Estimates for Key Metrics

Suncor Energy (SU) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures — Neutral

SU   Zacks Investment Research — January 30, 2026

Get a deeper insight into the potential performance of Suncor Energy (SU) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

image for news Suncor Energy (SU) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Leucipa Rollout Strengthens Baker Hughes' Digital Energy Footprint — Positive

BKR   Zacks Investment Research — January 30, 2026

BKR lands a multi-year deal with Expand Energy to deploy AI-powered Leucipa across shale wells, aiming to lift efficiency through real-time analytics.

image for news Leucipa Rollout Strengthens Baker Hughes' Digital Energy Footprint

VLY Stock Rallies 3.3% as Q4 Earnings Beat on Higher NII & Fee Income — Positive

VLY   Zacks Investment Research — January 30, 2026

Valley National shares gain 3.3% after Q4 earnings top estimates, driven by higher net interest income, strong fee income growth and rising loans and deposits.

image for news VLY Stock Rallies 3.3% as Q4 Earnings Beat on Higher NII & Fee Income

Sandisk blew away second-quarter earnings expectations and delivered strong third-quarter revenue guidance. The flash storage memory company reported 64% growth in its data center business.

image for news Sandisk stock soars 14% after blowout earnings report showing overwhelming AI demand

The Magnificent 7 Are Starting To Look Too Cheap To Ignore — Positive

AAPL  MSFT   24/7 Wall Street — January 30, 2026

The Magnificent Seven sailed into 2026 in a rather muted spot. While there has been a notable divergence in performance among the members, I do think that the group remains worth sticking with for the long haul, especially the names that have been viciously marked down.

image for news The Magnificent 7 Are Starting To Look Too Cheap To Ignore